{"@id":"https://bioecon.ru/technology/selective-organ-targeting-sort-lnp-extrahepatic/","@type":"Technology","cluster":"therapeutics-platforms","formats":{"html":"https://en.bioecon.ru/technology/selective-organ-targeting-sort-lnp-extrahepatic/","json":"https://en.bioecon.ru/api/v1/technology/selective-organ-targeting-sort-lnp-extrahepatic/index.json"},"id":"selective-organ-targeting-sort-lnp-extrahepatic","industries":["pharma","advanced-therapies"],"lang":"en","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/advanced-therapies/"],"suppliers":["https://bioecon.ru/companies/accra-compost-and-recycling-plant-limited/","https://bioecon.ru/companies/naturmega/","https://bioecon.ru/companies/brevel/","https://bioecon.ru/companies/holiferm/","https://bioecon.ru/companies/checkerspot/","https://bioecon.ru/companies/lonza-group/","https://bioecon.ru/companies/united-therapeutics/","https://bioecon.ru/companies/gsk/"]},"maturity":6,"name":"Selective Organ Targeting (SORT) Lipid Nanoparticles for Extrahepatic mRNA Delivery","regions":["us","eu","cn"],"risk":"medium","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-15","entity":"doi.org","kind":"research","urls":["https://doi.org/10.1016/j.mtbio.2026.103568","https://doi.org/10.3390/pharmaceutics18091094"]},{"date":"2026-11-15","entity":"recode-therapeutics","kind":"vendor","urls":[]},{"date":"2026-11-15","entity":"ut-southwestern-siegwart-lab","kind":"vendor","urls":[]}],"stages":[{"n":1,"title":"SORT lipid biophysical tailoring"},{"n":2,"title":"Microfluidic hydrodynamic mixing"},{"n":3,"title":"Serum protein corona remodeling"},{"n":4,"title":"Target organ endocytosis"}],"summary":"Incorporating systematic charged or zwitterionic SORT lipids into ionizable LNPs to engineer tissue biodistribution away from the liver directly to lungs, spleen, and bone marrow in vivo.","url":"/technology/selective-organ-targeting-sort-lnp-extrahepatic/","verified":"2026-11-15"}